Teva Pharmaceuticals USA, Inc. is the U.S. arm of a large pharmaceutical company that makes generic and brand-name drugs. Its filings show it lobbies on drug patent and exclusivity rules (like the Hatch-Waxman 180-day exclusivity), FDA drug approval processes, and implementation of the Inflation Reduction Act. It paid lobbyists and reported $240,000 across four filings through January 19, 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
MEGAN SUSSMAN HERBER
The latest disclosures for this client.
FAEGRE DRINKER BIDDLE & REATH LLP
Q3FAEGRE DRINKER BIDDLE & REATH LLP
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FAEGRE DRINKER BIDDLE & REATH LLP
mr ELLIOT VICE
FAEGRE DRINKER BIDDLE & REATH LLP
mr BRYAN MICHAEL ALLEN
FAEGRE DRINKER BIDDLE & REATH LLP
FAEGRE DRINKER BIDDLE & REATH LLP
Q1FAEGRE DRINKER BIDDLE & REATH LLP
Q4FAEGRE DRINKER BIDDLE & REATH LLP
Q3FAEGRE DRINKER BIDDLE & REATH LLP
Q2FAEGRE DRINKER BIDDLE & REATH LLP
Q1